StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — Prabhudas Lilladher

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1 year)25 Oct 2026via Moneycontrol Broker Research

Entry₹4,561.1Inferred
Target₹5,500
Total upside +20.58%
Stop lossNot given
CMP₹4,6701d ago
Active+2.39%+17.77%upside left 11 mo left
Follow Prabhudas Lilladher for new calls(71% target hit, 430 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 8 other Long-term calls on TORNTPHARMSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:31 am IST
14 supporting4 neutral5 opposing
Supports the BUY call (14)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

8 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·5 Nov · 1w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·29 Sept · 2mo ago

Neutral / worth noting (4)

Torrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·23 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (5)

Torrent Pharma Q2 Results: Net profit declines despite 51% revenue growth; misses estimates

NewsCnbc-Tv18·23 Oct · 3w ago

(opens in new tab)

Torrent accepts Kelshikar resignation: October 23 call for Torrent Pharmaceuticals stock

NewsGoogle News·19 Oct · 4w ago

(opens in new tab)

Torrent Pharmaceuticals accepts resignation of Executive Director Amal Kelshikar

NewsGoogle News·16 Oct · 4w ago

(opens in new tab)

Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director?

NewsGoogle News·16 Oct · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from Prabhudas Lilladher

Every call and its outcome